US5252608A
(en)
|
1988-02-25 |
1993-10-12 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5021456A
(en)
|
1988-02-25 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5182297A
(en)
|
1988-02-25 |
1993-01-26 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4943593A
(en)
|
1988-02-25 |
1990-07-24 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4965288A
(en)
|
1988-02-25 |
1990-10-23 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5059714A
(en)
|
1988-02-25 |
1991-10-22 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5120764A
(en)
|
1988-11-01 |
1992-06-09 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4997854A
(en)
|
1989-08-25 |
1991-03-05 |
Trustees Of Boston University |
Anti-fibrotic agents and methods for inhibiting the activity of lysyl oxidase in-situ using adjacently positioned diamine analogue substrates
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
EP0885205A4
(de)
|
1996-02-28 |
2002-11-27 |
Merck & Co Inc |
Fibrinogen-rezeptor-antagonisten
|
JP2001002661A
(ja)
|
1999-06-22 |
2001-01-09 |
Ricoh Co Ltd |
ニトリル化合物及びその製造方法
|
US6465648B1
(en)
|
1999-06-22 |
2002-10-15 |
Ricoh Company, Ltd. |
Reaction product, process of producing same, electrophotographic photoconductor using same, electrophotographic apparatus having the photoconductor, and process cartridge for electrophotographic apparatus
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
EP1296977A1
(de)
|
2000-06-23 |
2003-04-02 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl-substituierte factor xa inhibitoren
|
AU2001288617A1
(en)
|
2000-09-05 |
2002-03-22 |
Neogenesis Pharmaceuticals Inc. |
Methods for forming combinatorial libraries combining amide bond formation with epoxide opening
|
US20020115106A1
(en)
|
2000-12-22 |
2002-08-22 |
Neogenesis Pharmaceuticals, Inc. |
Methods for forming combinatorial libraries using reductive amination
|
DE10104279A1
(de)
|
2001-01-31 |
2002-08-01 |
Heinz Langhals |
Kompetitive Prionen-Reagenzien und ihre Anwendung in Diagnostik und Therapie
|
FR2828206B1
(fr)
|
2001-08-03 |
2004-09-24 |
Centre Nat Rech Scient |
Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
|
EP2168576A3
(de)
|
2001-09-14 |
2010-05-26 |
Shionogi & Co., Ltd. |
Trizyklische Verbindungen zur Behandlung der Dislipidämie und arteriosklerotischer Erkrankungen
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
CN1726189A
(zh)
|
2002-12-11 |
2006-01-25 |
伊莱利利公司 |
新颖的mch受体拮抗剂
|
US20040142958A1
(en)
|
2002-12-13 |
2004-07-22 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
CA2519677A1
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc. |
Biaryl substituted 6-membered heterocycles as sodium channel blockers
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
US7405295B2
(en)
|
2003-06-04 |
2008-07-29 |
Cgi Pharmaceuticals, Inc. |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
WO2005051890A1
(en)
|
2003-11-19 |
2005-06-09 |
Smithkline Beecham Corporation |
Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
|
US7432278B2
(en)
|
2004-03-08 |
2008-10-07 |
The University Of North Carolina At Chapel Hill |
Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
|
EP2253315A1
(de)
|
2004-03-30 |
2010-11-24 |
Takeda Pharmaceutical Company Limited |
Alkoxyphenylpropanoylsäure derivaten
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
US20060019967A1
(en)
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
WO2006038738A1
(ja)
|
2004-10-08 |
2006-04-13 |
Takeda Pharmaceutical Company Limited |
受容体機能調節剤
|
WO2006052566A2
(en)
|
2004-11-03 |
2006-05-18 |
Arena Pharmaceuticals, Inc. |
Gpr41 and modulators thereof for the treatment of insulin-related disorders
|
AU2006211514A1
(en)
|
2005-01-28 |
2006-08-10 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
AU2006210954A1
(en)
|
2005-01-31 |
2006-08-10 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
JP2008532933A
(ja)
|
2005-02-11 |
2008-08-21 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
置換イミダゾキノリン類および置換イミダゾナフチリジン類
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
KR101339628B1
(ko)
|
2005-05-09 |
2013-12-09 |
메다렉스, 인코포레이티드 |
예정 사멸 인자 1(pd-1)에 대한 인간 모노클로날 항체, 및 항-pd-1 항체를 단독 사용하거나 기타 면역 요법제와 병용한 암 치료 방법
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
US7465804B2
(en)
|
2005-05-20 |
2008-12-16 |
Amgen Inc. |
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
|
KR101888321B1
(ko)
|
2005-07-01 |
2018-08-13 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
US8153694B2
(en)
|
2005-07-29 |
2012-04-10 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
EP1924546A1
(de)
|
2005-09-14 |
2008-05-28 |
Amgen, Inc |
Konformationseingeschränkte 3- (4-hydroxy-phenyl) substitutierte propansäuren zur behandlung von stoffwechselstörungen
|
AU2006304400A1
(en)
|
2005-10-19 |
2007-04-26 |
Merck Sharp & Dohme Corp. |
CETP inhibitors
|
WO2007049050A2
(en)
|
2005-10-27 |
2007-05-03 |
Heptahelix Ab |
Modulators of gpr40 for the treatment of diabetes
|
WO2007052466A1
(ja)
|
2005-11-04 |
2007-05-10 |
Eisai R & D Management Co., Ltd. |
Gpr40とホスホリパーゼとを用いる疾患に有用な物質のスクリーニング方法
|
US20100249175A1
(en)
|
2005-12-02 |
2010-09-30 |
Wilson W David |
Dicationic compounds which selectively recognize G-quadruplex DNA
|
DK1976828T3
(en)
|
2005-12-29 |
2017-03-06 |
Celtaxsys Inc |
DIAMINE DERIVATIVES AS INhibitors of Leukotriene A4 HYDROLASE
|
WO2007096142A2
(en)
|
2006-02-22 |
2007-08-30 |
Philogen Spa |
Vascular tumor markers
|
EP2001844A2
(de)
|
2006-03-14 |
2008-12-17 |
Amgen, Inc |
Bicyclische carbonsäurederivate zur behandlung von stoffwechselerkrankungen
|
DE102006012251A1
(de)
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
|
SG170728A1
(en)
|
2006-03-23 |
2011-05-30 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
PL2004607T3
(pl)
|
2006-03-31 |
2012-03-30 |
Novartis Ag |
Pochodne kwasu (4-(4-[6-(trifluorometylopirydyn-3-yloamino)-N-zawierające-heteroarylo]-fenylo)-cykloheksylo)-octowego i ich farmaceutyczne zastosowania
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
EP1849781A1
(de)
|
2006-04-28 |
2007-10-31 |
Laboratorios del Dr. Esteve S.A. |
3-Amino-4-hydroxy pyrrolidine Derivate, Methode zur Herstellung und Gebrauch als Medikamente
|
EP2021338A1
(de)
|
2006-05-09 |
2009-02-11 |
Pfizer Products Inc. |
Cycloalkylaminosäurederivate und pharmazeutische zusammensetzung davon
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2651658A1
(en)
|
2006-05-11 |
2007-11-22 |
Sanofi-Aventis |
4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP5271895B2
(ja)
|
2006-05-15 |
2013-08-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
抗糖尿病性の二環式化合物
|
EP2041123B9
(de)
|
2006-06-27 |
2013-01-02 |
Takeda Pharmaceutical Company Limited |
Kondensierte cyclische verbindungen
|
WO2008014236A1
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2064193A1
(de)
|
2006-09-07 |
2009-06-03 |
Amgen, Inc |
Heterozyklische gpr40-modulatoren
|
WO2008037266A1
(en)
|
2006-09-25 |
2008-04-03 |
Universite Libre De Bruxelles |
Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases
|
US8338394B2
(en)
|
2006-10-12 |
2012-12-25 |
Case Western Reserve University |
Methods for treating metabolic diseases
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
EP2079467B1
(de)
|
2006-10-31 |
2015-11-18 |
Merck Sharp & Dohme Corp. |
Antidiabetische bicyclische verbindungen
|
US7750048B2
(en)
|
2006-11-15 |
2010-07-06 |
Janssen Pharmaceutica Nv |
GPR40 agonists
|
TW200838526A
(en)
|
2006-12-01 |
2008-10-01 |
Astellas Pharma Inc |
Carboxylic acid derivatives
|
WO2008065409A2
(en)
|
2006-12-01 |
2008-06-05 |
Betagenon Ab |
Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor
|
JP2010511635A
(ja)
|
2006-12-04 |
2010-04-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Hiv複製の阻害剤
|
CA2671315A1
(en)
|
2006-12-11 |
2008-06-19 |
Novartis Ag |
Method of preventing or treating myocardial ischemia by inhibiting dgat1 enzyme with a dgat1 inhibitor
|
AU2007338792B2
(en)
|
2006-12-20 |
2012-05-31 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
EP2121692B1
(de)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituierte heterozyklen als inhibitoren von janus-kinase
|
PL2698062T3
(pl)
|
2006-12-28 |
2015-12-31 |
Abbvie Inc |
Inhibitory polimerazy poli(adp-rybozy)
|
WO2008090327A1
(en)
|
2007-01-22 |
2008-07-31 |
Betagenon Ab |
New combination for use in the treatment of cancer
|
WO2008090356A1
(en)
|
2007-01-25 |
2008-07-31 |
Betagenon Ab |
Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity
|
WO2008106202A1
(en)
|
2007-02-27 |
2008-09-04 |
Housey Gerard M |
Theramutein modulators
|
EP3023422A1
(de)
|
2007-03-12 |
2016-05-25 |
YM BioSciences Australia Pty Ltd |
Phenylaminopyrimidinverbindungen und verwendungen davon
|
CA2683751C
(en)
|
2007-04-16 |
2013-01-08 |
Amgen Inc. |
Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
|
US8318781B2
(en)
|
2007-04-26 |
2012-11-27 |
Japan Science And Technology Agency |
G-protein-conjugated receptor agonist
|
WO2008147852A1
(en)
|
2007-05-22 |
2008-12-04 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
US20100203012A1
(en)
|
2007-05-30 |
2010-08-12 |
Aegera Therapeutics, Inc. |
Iap bir domain binding compounds
|
EP2002838A1
(de)
|
2007-06-13 |
2008-12-17 |
Bayer Schering Pharma AG |
Verwendung von Aryl/Hetarylamid-Derivaten als Modulatoren des EP2-Rezeptors
|
WO2008156656A2
(en)
|
2007-06-13 |
2008-12-24 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for making biaryl compounds, compounds made by the method, and method for their use
|
PT2170888E
(pt)
|
2007-06-29 |
2015-08-21 |
Gilead Sciences Inc |
Purina derivados e sua utilização como moduladores de recetor de tipo toll 7
|
SI2182981T1
(sl)
|
2007-08-02 |
2013-05-31 |
Gilead Biologics, Inc. |
Postopki in sestavki za zdravljenje in diagnozo fibroze
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
TWI649303B
(zh)
|
2007-08-17 |
2019-02-01 |
杜邦股份有限公司 |
製備4-乙醯基-n-〔2-側氧基-2-〔(2,2,2-三氟乙基)胺基〕乙基〕-1-萘甲醯胺之化合物及方法
|
WO2009038204A1
(ja)
|
2007-09-17 |
2009-03-26 |
Pharma Frontier Co., Ltd. |
新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするgタンパク質共役型レセプター作動剤
|
MY149648A
(en)
|
2007-09-21 |
2013-09-30 |
Sanofi Aventis |
Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
|
EP2203415B1
(de)
|
2007-09-21 |
2016-10-26 |
Sanofi |
(cyclopropyl-phenyl)-phenyl-oxalamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
ES2446932T3
(es)
|
2007-10-08 |
2014-03-10 |
Advinus Therapeutics Private Limited |
Derivados de acetamida como activadores de glucoquinasa, su procedimiento y aplicaciones en medicina
|
BRPI0818253A2
(pt)
|
2007-10-10 |
2015-04-07 |
Amgen Inc |
Moduladores de gpr40 bifenil substituídos
|
JP2011016722A
(ja)
|
2007-10-23 |
2011-01-27 |
Astellas Pharma Inc |
チアゾリジンジオン化合物
|
AU2008314922B2
(en)
|
2007-10-24 |
2013-08-29 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
EP2684861A3
(de)
|
2007-10-26 |
2014-05-07 |
Japan Tobacco Inc. |
Spiroverbindungen und pharmazeutische Verwendung dafür
|
EP2215068B1
(de)
|
2007-10-29 |
2012-06-13 |
Merck Sharp & Dohme Corp. |
Antidiabetische tricyclische verbindungen
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2260017A1
(de)
|
2008-03-06 |
2010-12-15 |
Amgen, Inc |
Konformationseingeschränkte carbonsäurederivate, die sich für die behandlung von stoffwechselerkrankungen eignen
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
CN104042611B
(zh)
|
2008-07-08 |
2019-05-14 |
因塞特控股公司 |
作为吲哚胺2,3-双加氧酶的抑制剂的1,2,5-噁二唑
|
US8450460B2
(en)
|
2008-07-21 |
2013-05-28 |
Apogenix Gmbh |
Single-chain TNFSF fusion polypeptides
|
JP2012503595A
(ja)
|
2008-07-28 |
2012-02-09 |
シダンスク ユニバーシティ |
代謝病の治療用の化合物
|
DK2313111T3
(da)
|
2008-08-01 |
2013-12-02 |
Ventirx Pharmaceuticals Inc |
Toll-lignende receptoragonistformuleringer og anvendelse deraf
|
WO2010019702A2
(en)
|
2008-08-12 |
2010-02-18 |
Oncomed Pharmaceuticals, Inc. |
Ddr1-binding agents and methods of use thereof
|
DE102008037790A1
(de)
|
2008-08-14 |
2010-02-18 |
Merck Patent Gmbh |
Bicyclische Triazolderivate
|
CA2739303A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
JP5551707B2
(ja)
|
2008-10-15 |
2014-07-16 |
アムジエン・インコーポレーテツド |
スピロ環gpr40調節因子
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
KR20110097930A
(ko)
|
2008-12-08 |
2011-08-31 |
유로 스크린 에스.에이. |
화합물, 약학조성 및 대사장애의 치료에 사용하는 방법
|
PT2364314E
(pt)
|
2008-12-09 |
2014-06-09 |
Gilead Sciences Inc |
Moduladores de recetores toll-like
|
JP2012513409A
(ja)
|
2008-12-23 |
2012-06-14 |
アボット・ラボラトリーズ |
抗ウイルス化合物
|
KR20110110183A
(ko)
|
2009-01-19 |
2011-10-06 |
다이이찌 산쿄 가부시키가이샤 |
헤테로 원자를 갖는 고리형 화합물
|
WO2010085522A1
(en)
|
2009-01-23 |
2010-07-29 |
Schering Corporation |
Pentafluorosulpholane-containing antidiabetic compounds
|
US20110312995A1
(en)
|
2009-01-23 |
2011-12-22 |
Schering Corporation |
Bridged and fused heterocyclic antidiabetic compounds
|
CA2749891A1
(en)
|
2009-01-23 |
2010-07-29 |
Hubert B. Josien |
Bridged and fused antidiabetic compounds
|
EP2393810A1
(de)
|
2009-02-05 |
2011-12-14 |
Schering Corporation |
Phthalazinhaltige antidiabetische verbindungen
|
EP2393359A4
(de)
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
Verbundene dibenzimidazolderivate
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
EP2400846B1
(de)
|
2009-02-27 |
2016-10-05 |
Enanta Pharmaceuticals, Inc. |
Hemmer des hepatitis-c-virus
|
BRPI1012282A2
(pt)
|
2009-03-27 |
2015-09-22 |
Presidio Pharmaceuticals Inc |
inibidores de anel fundidos da hepatite c.
|
RU2011147232A
(ru)
|
2009-04-22 |
2013-05-27 |
Астеллас Фарма Инк. |
Производное карбоновой кислоты
|
JP2012136438A
(ja)
|
2009-04-22 |
2012-07-19 |
Astellas Pharma Inc |
テトラゾール化合物
|
CN109020961A
(zh)
|
2009-05-13 |
2018-12-18 |
吉利德制药有限责任公司 |
抗病毒化合物
|
US20120172351A1
(en)
|
2009-06-09 |
2012-07-05 |
Nobuyuki Negoro |
Novel fused cyclic compound and use thereof
|
DK2455376T3
(en)
|
2009-06-11 |
2015-03-02 |
Abbvie Bahamas Ltd |
Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
|
TWI625121B
(zh)
|
2009-07-13 |
2018-06-01 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
AU2010284240B2
(en)
|
2009-08-18 |
2016-11-10 |
Array Biopharma, Inc. |
Substituted benzoazepines as Toll-like receptor modulators
|
AU2010284241B2
(en)
|
2009-08-18 |
2016-11-10 |
Array Biopharma, Inc. |
Substituted benzoazepines as Toll-like receptor modulators
|
GB0914856D0
(en)
|
2009-08-25 |
2009-09-30 |
Ark Therapeutics Ltd |
Compounds
|
WO2011031934A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
NO2477987T3
(de)
|
2009-09-14 |
2018-06-09 |
|
|
BR112012007979A2
(pt)
|
2009-10-06 |
2016-03-29 |
Bristol Myers Squibb Co |
moduladores de gpr40 de pirrolidina
|
AR078522A1
(es)
|
2009-10-15 |
2011-11-16 |
Lilly Co Eli |
Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
|
AU2010310813B2
(en)
|
2009-10-22 |
2015-06-18 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
WO2012109263A1
(en)
|
2011-02-07 |
2012-08-16 |
The Washington University |
Mannoside compounds and methods of use thereof
|
WO2011052756A1
(ja)
|
2009-10-30 |
2011-05-05 |
持田製薬株式会社 |
新規3-ヒドロキシ-5-アリールイソキサゾール誘導体
|
EP2499282B1
(de)
|
2009-11-09 |
2015-04-22 |
NeuroGenetic Pharmaceuticals, Inc. |
Gamma-sekretase-modulierende verbindungen, verfahren zu ihrer identifikation und verwendungen dafür
|
CA2782024A1
(en)
|
2009-11-25 |
2011-06-03 |
Schering Corporation |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
AR078948A1
(es)
|
2009-11-30 |
2011-12-14 |
Lilly Co Eli |
Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
|
PT2513053T
(pt)
|
2009-12-18 |
2018-01-09 |
Ogeda Sa |
Derivados de ácido carboxílico de pirrolidina como agonistas de recetor 43 acoplado à proteína g (gpr43), composição farmacêutica e métodos para utilização no tratamento de distúrbios metabólicos
|
WO2011076734A1
(en)
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
|
WO2011076732A1
(en)
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders
|
EA201290574A1
(ru)
|
2009-12-25 |
2012-12-28 |
Мотида Фармасьютикал Ко., Лтд. |
Новое производное 3-гидрокси-5-арилизотиазола
|
WO2011080755A1
(en)
|
2009-12-29 |
2011-07-07 |
Advinus Therapeutics Private Limited |
Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
WO2011092284A1
(en)
|
2010-01-29 |
2011-08-04 |
Euroscreen S.A. |
Novel amino acid derivatives and their use as gpr43 receptor modulators
|
CN105622757A
(zh)
|
2010-02-04 |
2016-06-01 |
吉联亚生物科技有限公司 |
结合赖氨酰氧化酶样2(loxl2)的抗体和其使用方法
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
TW201139438A
(en)
|
2010-03-24 |
2011-11-16 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
TW201200522A
(en)
|
2010-03-24 |
2012-01-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
JP2013523746A
(ja)
|
2010-03-30 |
2013-06-17 |
ノバルティス アーゲー |
Dgat1阻害剤の使用
|
US8686048B2
(en)
|
2010-05-06 |
2014-04-01 |
Rhizen Pharmaceuticals Sa |
Immunomodulator and anti-inflammatory compounds
|
MX2012013031A
(es)
|
2010-05-12 |
2012-12-17 |
Univ Vanderbilt |
Potenciadores alostericos mglur4 de sulfona heterociclica, composiciones y metodos para tratar disfuncion neurologica.
|
CN103179976A
(zh)
|
2010-05-13 |
2013-06-26 |
印第安纳大学研究及科技有限公司 |
呈现g蛋白偶联受体活性的胰高血糖素超家族肽
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
SG185617A1
(en)
|
2010-05-31 |
2012-12-28 |
Ono Pharmaceutical Co |
Purinone derivative
|
WO2011151436A2
(en)
|
2010-06-04 |
2011-12-08 |
Euroscreen S.A. |
Novel compounds, method for use them and pharmaceutical composition containing them
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
JP2012036168A
(ja)
|
2010-07-15 |
2012-02-23 |
Daiichi Sankyo Co Ltd |
ヘテロ原子を有する環状化合物を含有する医薬組成物
|
WO2012011124A1
(en)
|
2010-07-20 |
2012-01-26 |
Council Of Scientific & Industrial Research |
Ordered mesoporous titanosilicate and the process for the preparation thereof
|
WO2012012627A1
(en)
|
2010-07-22 |
2012-01-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of preventing or treating viral infection
|
PE20131376A1
(es)
|
2010-08-27 |
2013-11-25 |
Gilead Biologics Inc |
Anticuerpos para metaloproteinasa-9 de matriz
|
WO2012036168A1
(ja)
|
2010-09-14 |
2012-03-22 |
北海道公立大学法人札幌医科大学 |
筋ジストロフィーを処置するための組成物
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
SG189071A1
(en)
|
2010-10-01 |
2013-05-31 |
Ventirx Pharmaceuticals Inc |
Therapeutic use of a tlr agonist and combination therapy
|
CN103237549A
(zh)
|
2010-10-01 |
2013-08-07 |
帆德制药股份有限公司 |
过敏性疾病的治疗方法
|
CA2813639A1
(en)
|
2010-10-08 |
2012-04-12 |
Mochida Pharmaceutical Co. Ltd. |
Cyclic amide derivative
|
US9474275B2
(en)
|
2010-11-15 |
2016-10-25 |
Bayer Intellectual Property Gmbh |
Cyanoenamines and their use as fungicides
|
JP5905020B2
(ja)
|
2010-11-17 |
2016-04-20 |
ギリアド ファーマセット エルエルシー |
抗ウイルス化合物
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
DK2646425T3
(en)
|
2010-12-01 |
2015-08-24 |
Boehringer Ingelheim Int |
Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome.
|
WO2012078802A1
(en)
|
2010-12-08 |
2012-06-14 |
Takeda Pharmaceutical Company Limited |
PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES
|
CN107699585A
(zh)
|
2010-12-09 |
2018-02-16 |
宾夕法尼亚大学董事会 |
嵌合抗原受体‑修饰的t细胞治疗癌症的用途
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
EP2651923A4
(de)
|
2010-12-15 |
2014-06-18 |
Abbvie Inc |
Antivirale verbindungen
|
WO2012083061A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
WO2012083053A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
EP2651927A4
(de)
|
2010-12-15 |
2014-06-04 |
Abbvie Inc |
Antivirale verbindungen
|
US20150158909A1
(en)
|
2010-12-15 |
2015-06-11 |
Abbevie Inc. |
Anti-viral compounds
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
EP2663550B1
(de)
|
2011-01-12 |
2016-12-14 |
VentiRx Pharmaceuticals, Inc. |
Substituierte benzoazepine als toll-like-rezeptor-modulatoren
|
WO2012097177A2
(en)
|
2011-01-12 |
2012-07-19 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
CN103328442A
(zh)
|
2011-01-19 |
2013-09-25 |
加拉帕戈斯股份有限公司 |
可用于治疗代谢性和炎性疾病的氮杂环丁烷衍生物
|
SG192126A1
(en)
|
2011-01-25 |
2013-09-30 |
Univ Michigan |
Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
|
PE20140844A1
(es)
|
2011-02-12 |
2014-07-14 |
Globeimmune Inc |
Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
|
US8952185B2
(en)
|
2011-02-17 |
2015-02-10 |
Takeda Pharmaceutical Company Limited |
Production method of optically active dihydrobenzofuran derivative
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
EP3590928B1
(de)
|
2011-04-08 |
2021-06-09 |
Janssen Sciences Ireland Unlimited Company |
Pyrimidinderivate zur behandlung von virusinfektionen
|
US9499467B2
(en)
|
2011-04-08 |
2016-11-22 |
Caldan Therapeutics Limited |
Ortho-fluoro substituted compounds for the treatment of metabolic diseases
|
NZ617409A
(en)
|
2011-04-27 |
2015-08-28 |
Mochida Pharm Co Ltd |
Novel 3-hydroxyisothiazole 1-oxide derivative
|
WO2012154608A1
(en)
|
2011-05-06 |
2012-11-15 |
Intellikine, Llc |
Reactive mtor and pi3 kinase inhibitors and uses thereof
|
JP5659189B2
(ja)
|
2011-05-13 |
2015-01-28 |
富士フイルム株式会社 |
非共鳴2光子吸収材料、非共鳴2光子吸収記録材料、記録媒体、記録再生方法及び非共鳴2光子吸収化合物
|
NO2709989T3
(de)
|
2011-05-18 |
2018-05-19 |
|
|
TWI567061B
(zh)
|
2011-07-01 |
2017-01-21 |
吉李德科學股份有限公司 |
用於治療成癮之化合物
|
EP2817304A4
(de)
|
2011-07-14 |
2015-01-21 |
Biochromix Newco Ab |
Neue verbindungen und ihre therapeutische verwendung
|
AR087451A1
(es)
|
2011-08-17 |
2014-03-26 |
Lilly Co Eli |
Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
|
JP6101205B2
(ja)
|
2011-08-23 |
2017-03-22 |
中外製薬株式会社 |
抗腫瘍活性を有する新規な抗ddr1抗体
|
GB201115529D0
(en)
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
WO2013052699A2
(en)
|
2011-10-04 |
2013-04-11 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
WO2013057743A1
(en)
|
2011-10-21 |
2013-04-25 |
Connexios Life Sciences Pvt. Ltd |
Process for the preparation of an aryl oxime and salts thereof
|
LT2786996T
(lt)
|
2011-11-29 |
2017-01-10 |
Ono Pharmaceutical Co., Ltd. |
Purinono darinio hidrochloridas
|
EA037918B1
(ru)
|
2011-12-21 |
2021-06-07 |
Новира Терапьютикс, Инк. |
Противовирусные агенты против гепатита в
|
EP2800736A1
(de)
|
2012-01-04 |
2014-11-12 |
Sanofi |
[3-4-(phenylaminooxalylamino)phenyl]hex-4-ynoesäuren, verfahren zur herstellung davon und verwendung davon als arzneimittel
|
WO2013104257A1
(zh)
|
2012-01-12 |
2013-07-18 |
江苏恒瑞医药股份有限公司 |
多环类衍生物、其制备方法及其在医药上的应用
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2013109521A1
(en)
|
2012-01-16 |
2013-07-25 |
Vertex Pharmaceuticals Incorporated |
Pyran-spirocyclic piperidine amides as modulators of ion channels
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
WO2013116562A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Calistoga Llc |
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile
|
EP2812331B1
(de)
|
2012-02-08 |
2019-01-02 |
Janssen Sciences Ireland Unlimited Company |
Piperidinopyrimidinderivate zur behandlung von virusinfektionen
|
US9181186B2
(en)
|
2012-02-13 |
2015-11-10 |
Takeda Pharmaceutical Company Limited |
Aromatic ring compound
|
EP2816023A4
(de)
|
2012-02-13 |
2015-09-09 |
Takeda Pharmaceutical |
Aromatische ringverbindung
|
IN2014MN01839A
(de)
|
2012-02-28 |
2015-07-03 |
Piramal Entpr Ltd |
|
US8642585B2
(en)
|
2012-03-26 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
KR20140143160A
(ko)
|
2012-03-31 |
2014-12-15 |
에프. 호프만-라 로슈 아게 |
B형 간염 바이러스 감염의 치료 및 예방을 위한 신규한 4-메틸-다이하이드로피리미딘
|
WO2013154163A1
(ja)
|
2012-04-11 |
2013-10-17 |
持田製薬株式会社 |
新規5-アリール-1,2-チアジナン誘導体
|
US8809376B2
(en)
|
2012-04-30 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
EP2852585A1
(de)
|
2012-05-11 |
2015-04-01 |
AbbVie Inc. |
Nampt-inhibitoren
|
JP2015520752A
(ja)
|
2012-05-11 |
2015-07-23 |
アッヴィ・インコーポレイテッド |
Nampt阻害薬としてのピリダジンおよびピリジン誘導体
|
US8633182B2
(en)
|
2012-05-30 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
Indanyloxyphenylcyclopropanecarboxylic acids
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
PL2859009T3
(pl)
|
2012-06-08 |
2018-03-30 |
Gilead Sciences, Inc. |
Makrocykliczne inhibitory wirusów flaviviridae
|
CA2875692A1
(en)
|
2012-06-08 |
2013-12-12 |
Selcia Limited |
Macrocyclic inhibitors of flaviviridae viruses
|
US20140024708A1
(en)
|
2012-07-17 |
2014-01-23 |
Banavara L. Mylari |
Ursolic acid salts for treating diabetes and obesity
|
JP2015127299A
(ja)
|
2012-07-19 |
2015-07-09 |
武田薬品工業株式会社 |
固形製剤
|
WO2014019186A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
MY183534A
(en)
|
2012-08-10 |
2021-02-25 |
Janssen Sciences Ireland Uc |
Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
|
ES2711425T3
(es)
|
2012-08-27 |
2019-05-03 |
Allergan Inc |
Espesamiento de la córnea central reducido mediante el uso de profármacos de éster hidrófilos de beta-clorociclopentanos
|
CR20200276A
(es)
|
2012-08-28 |
2021-01-27 |
Janssen Sciences Ireland Uc |
Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059)
|
DK2890683T3
(en)
|
2012-08-28 |
2017-01-30 |
Janssen Sciences Ireland Uc |
MERGED BICYCLIC SULFAMOYL DERIVATIVES AND THEIR USE AS MEDICINES TO TREAT HEPATITIS B
|
PE20150776A1
(es)
|
2012-09-10 |
2015-05-21 |
Hoffmann La Roche |
6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b
|
US20140073631A1
(en)
|
2012-09-12 |
2014-03-13 |
Vymed Corporation |
Antiviral and antimicrobial compounds
|
WO2014047624A1
(en)
|
2012-09-24 |
2014-03-27 |
Gilead Sciences, Inc. |
Anti-ddr1 antibodies
|
PL2903968T3
(pl)
|
2012-10-02 |
2017-05-31 |
Gilead Sciences, Inc. |
Inhibitory demetylaz histonowych
|
CA2884478C
(en)
|
2012-10-10 |
2021-02-16 |
Janssen Sciences Ireland Uc |
Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
|
EP2911669B1
(de)
|
2012-10-26 |
2024-04-10 |
The University of Chicago |
Synergistische kombination von immunologischen inhibitoren zur behandlung von krebs
|
US20140128333A1
(en)
|
2012-11-02 |
2014-05-08 |
Maqui New Life S.A. |
Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release
|
TWI692469B
(zh)
|
2012-11-09 |
2020-05-01 |
南韓商Lg化學股份有限公司 |
Gpr40受體促效劑,製造該促效劑的方法以及含有該促效劑作爲活性劑的醫藥組成物
|
KR101268466B1
(ko)
|
2012-11-12 |
2013-06-04 |
유병수 |
사축형 윈드 터빈
|
CA2891535A1
(en)
|
2012-11-16 |
2014-05-22 |
Bristol-Myers Squibb Company |
Dihydropyrazole gpr40 modulators
|
SI2920165T1
(sl)
|
2012-11-16 |
2017-02-28 |
Bristol-Myers Squibb Company |
Modulatorji dihidropirazola GPR40
|
EP2925741B1
(de)
|
2012-11-16 |
2016-10-26 |
Bristol-Myers Squibb Company |
Pyrrolidin-gpr40-modulatoren
|
AU2013346793B2
(en)
|
2012-11-16 |
2018-03-08 |
Janssen Sciences Ireland Uc |
Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
|
JP2016501203A
(ja)
|
2012-11-20 |
2016-01-18 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インドールアミン2,3−ジオキシゲナーゼの阻害剤として有用な化合物
|
EP2925748B1
(de)
|
2012-11-28 |
2017-01-11 |
Boehringer Ingelheim International GmbH |
Indanyloxydihydrobenzofuranyl essigsäuren als modulatoren des g-protein gekoppelten rezeptors (gpr40) und des freie fettsäure rezeptors 1 (ffar1) zur behandlung von stoffwechselerkraankungen
|
WO2014089364A1
(en)
|
2012-12-06 |
2014-06-12 |
Quanticel Pharmaceuticals, Inc |
Histone demethylase inhibitors
|
JP6283862B2
(ja)
|
2012-12-07 |
2018-02-28 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規インダニルオキシジヒドロベンゾフラニル酢酸
|
PT2934145T
(pt)
|
2012-12-19 |
2018-02-13 |
Celgene Quanticel Res Inc |
Inibidores de histona demetilase
|
CA2895782C
(en)
|
2012-12-21 |
2017-08-22 |
Gilead Calistoga Llc |
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
|
NZ708870A
(en)
|
2012-12-21 |
2016-09-30 |
Gilead Calistoga Llc |
Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
|
WO2014100818A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
JP6404835B2
(ja)
|
2013-02-21 |
2018-10-17 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染の治療のための2−アミノピリミジン誘導体
|
CA2898482A1
(en)
|
2013-02-22 |
2014-08-28 |
Linda L. Brockunier |
Antidiabetic bicyclic compounds
|
US9642843B2
(en)
|
2013-02-27 |
2017-05-09 |
The Regents Of The University Of Michigan |
Pharmaceutical compounds and use of same in cancer and tauopathies
|
CN105263906B
(zh)
|
2013-02-27 |
2018-11-23 |
吉利德科学公司 |
组蛋白脱甲基酶的抑制剂
|
ES2709195T3
(es)
|
2013-02-28 |
2019-04-15 |
Tiumbio Co Ltd |
Compuesto tricíclico y uso del mismo
|
HUE034820T2
(en)
|
2013-02-28 |
2018-02-28 |
Janssen Sciences Ireland Uc |
Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
|
JP6320506B2
(ja)
|
2013-03-12 |
2018-05-09 |
セルジーン クオンティセル リサーチ,インク. |
ヒストンデメチラーゼ阻害剤
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
EP2970307B1
(de)
|
2013-03-13 |
2020-03-11 |
Genentech, Inc. |
Pyrazolverbindungen und verwendungen davon
|
ES2731773T3
(es)
|
2013-03-14 |
2019-11-19 |
Celgene Quanticel Res Inc |
Inhibidores de la histona desmetilasa
|
US9763905B2
(en)
|
2013-03-15 |
2017-09-19 |
The Children's Medical Center Corporation |
Therapeutic target for the treatment of cancers and related therapies and methods
|
PL2970211T3
(pl)
|
2013-03-15 |
2018-01-31 |
Quanticel Pharmaceuticals Inc |
Inhibitory demetylazy histonowej
|
CN104059039B
(zh)
|
2013-03-22 |
2017-03-15 |
正大天晴药业集团股份有限公司 |
具有gpr40受体功能调节作用的稠环化合物
|
HUE033542T2
(en)
|
2013-04-03 |
2017-12-28 |
Janssen Sciences Ireland Uc |
Their use as medicaments for the treatment of N-phenylcarboxamide derivatives and hepatitis B
|
CN104109115B
(zh)
|
2013-04-16 |
2016-11-23 |
中国科学院上海药物研究所 |
一种含氮杂环链接的苯丙酸类化合物、其药物组合物、制备方法和用途
|
AR096041A1
(es)
|
2013-04-17 |
2015-12-02 |
Piramal Entpr Ltd |
Derivados de ácido carboxílico alquilo sustituidos como agonistas rpg
|
KR101569522B1
(ko)
|
2013-04-18 |
2015-11-17 |
현대약품 주식회사 |
신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
JP6533217B2
(ja)
|
2013-05-17 |
2019-06-19 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療および予防のための6−架橋ヘテロアリールジヒドロピリミジン類
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
CN105960400B
(zh)
|
2013-05-17 |
2019-05-31 |
爱尔兰詹森科学公司 |
氨磺酰基噻吩酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
CN104870429B
(zh)
|
2013-05-22 |
2017-05-03 |
四川海思科制药有限公司 |
苯并呋喃衍生物、其制备方法及其在医药上的应用
|
JP6030783B2
(ja)
|
2013-06-14 |
2016-11-24 |
ギリアード サイエンシーズ, インコーポレイテッド |
ホスファチジルイノシトール3−キナーゼ阻害剤
|
WO2015000412A1
(zh)
|
2013-07-02 |
2015-01-08 |
四川海思科制药有限公司 |
苯并环丁烯类衍生物、其制备方法及其在医药上的应用
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
JP6730183B2
(ja)
|
2013-07-12 |
2020-07-29 |
ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー |
シストバクトアミド(Cystobactamides)
|
WO2015011281A1
(en)
|
2013-07-25 |
2015-01-29 |
Janssen R&D Ireland |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015010655A1
(zh)
|
2013-07-26 |
2015-01-29 |
四川海思科制药有限公司 |
三元并环羧酸类衍生物、其制备方法及其在医药上的应用
|
US9657023B2
(en)
|
2013-07-30 |
2017-05-23 |
Gilead Connecticut, Inc. |
Polymorph of Syk inhibitors
|
RS57359B1
(sr)
|
2013-08-09 |
2018-08-31 |
Takeda Pharmaceuticals Co |
Aromatično jedinjenje
|
CN104418801B
(zh)
|
2013-08-19 |
2016-10-05 |
上海润诺生物科技有限公司 |
苯并哌啶环与苯并吗啉环类化合物、其制法及医药应用
|
US20160200734A1
(en)
|
2013-08-23 |
2016-07-14 |
Xinshan Kang |
Carboxylic acid compounds in treatment of diabetes mellitus
|
EP3039019B1
(de)
|
2013-08-26 |
2020-04-22 |
Purdue Pharma L.P. |
Azaspiro[4.5]decan-derivate und verwendung davon
|
WO2015028960A1
(en)
|
2013-08-28 |
2015-03-05 |
Piramal Enterprises Limited |
Substituted heterocyclic derivatives as gpr agonists and uses thereof
|
WO2015032328A1
(zh)
|
2013-09-03 |
2015-03-12 |
四川海思科制药有限公司 |
茚满衍生物及其制备方法和在医药上的应用
|
ES2642074T3
(es)
|
2013-09-04 |
2017-11-15 |
Bristol-Myers Squibb Company |
Compuestos útiles como inmunomoduladores
|
SG11201601682RA
(en)
|
2013-09-06 |
2016-04-28 |
Aurigene Discovery Tech Ltd |
1,2,4-oxadiazole derivatives as immunomodulators
|
AU2014320463B2
(en)
|
2013-09-11 |
2018-08-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection
|
JP6533778B2
(ja)
|
2013-09-26 |
2019-06-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Gpr40アゴニストとしてのインダニルオキシジヒドロベンゾフラニル酢酸誘導体を調製するための方法および中間体
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
UA117261C2
(uk)
|
2013-10-23 |
2018-07-10 |
ЯНССЕН САЙЄНСЕЗ АЙРЛЕНД ЮСі |
Похідні карбоксаміду та їх застосування як медикаментів для лікування гепатиту b
|
CN104592211B
(zh)
|
2013-10-31 |
2018-10-16 |
广东东阳光药业有限公司 |
联苯类化合物及其用途
|
JP6352415B2
(ja)
|
2013-11-14 |
2018-07-04 |
カディラ・ヘルスケア・リミテッド |
新規なヘテロ環化合物
|
AU2014348518B2
(en)
|
2013-11-14 |
2019-01-03 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EP3068768B1
(de)
|
2013-11-15 |
2019-07-31 |
Merck Sharp & Dohme Corp. |
Antidiabetische tricyclische verbindungen
|
WO2015076800A1
(en)
|
2013-11-21 |
2015-05-28 |
Ptc Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
EP3610872A1
(de)
|
2013-11-27 |
2020-02-19 |
Epics Therapeutics |
Verbindungen, pharmazeutische zusammensetzung und verfahren zur verwendung bei der behandlung von entzündungskrankheiten
|
WO2015078802A1
(en)
|
2013-11-28 |
2015-06-04 |
Boehringer Ingelheim International Gmbh |
New indanyloxyphenylcyclopropanecarboxylic acids
|
EP3076959B1
(de)
|
2013-12-04 |
2018-07-04 |
Merck Sharp & Dohme Corp. |
Antidiabetische bicyclische verbindungen
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
TW201609722A
(zh)
|
2013-12-13 |
2016-03-16 |
美國禮來大藥廠 |
新穎三唑并吡啶化合物
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
UY35898A
(es)
|
2013-12-23 |
2015-07-31 |
Gilead Sciences Inc |
?compuestos inhibidores de syk y composiciones que los comprenden?.
|
CN105899509B
(zh)
|
2014-01-10 |
2018-01-02 |
伊莱利利公司 |
异丙基三唑并吡啶化合物
|
KR20160095117A
(ko)
|
2014-01-10 |
2016-08-10 |
일라이 릴리 앤드 캄파니 |
페닐-트리아졸로-피리딘 화합물
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
CA2931329A1
(en)
|
2014-01-30 |
2015-08-06 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
WO2015119899A1
(en)
|
2014-02-06 |
2015-08-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic compounds
|
AU2015214961B2
(en)
|
2014-02-06 |
2018-08-30 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
RS58384B1
(sr)
|
2014-03-07 |
2019-04-30 |
Hoffmann La Roche |
Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b
|
EP3119763A1
(de)
|
2014-03-18 |
2017-01-25 |
Iteos Therapeutics |
Neuartige 3-indol-substituierte derivate, pharmazeutische zusammensetzungen und verfahren zur verwendung
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
CN106715417B
(zh)
|
2014-04-04 |
2020-01-14 |
爱欧梅特制药公司 |
药物中使用的吲哚衍生物
|
JP6765968B2
(ja)
|
2014-04-10 |
2020-10-07 |
シアトル チルドレンズ ホスピタル, ディービーエー シアトル チルドレンズ リサーチ インスティテュート |
薬物制御による導入遺伝子の発現
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
SG11201609167RA
(en)
|
2014-05-07 |
2016-12-29 |
Bristol Myers Squibb Co |
Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes
|
TWI659951B
(zh)
|
2014-05-07 |
2019-05-21 |
美商必治妥美雅史谷比公司 |
吡咯啶gpr40調節劑
|
EP3140294A1
(de)
|
2014-05-07 |
2017-03-15 |
Bristol-Myers Squibb Company |
Pyrrolidin-gpr40-modulatoren
|
CN106459032B
(zh)
|
2014-05-13 |
2019-04-05 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的新的二氢喹嗪酮类
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2015188085A1
(en)
|
2014-06-06 |
2015-12-10 |
Flexus Biosciences, Inc. |
Immunoregulatory agents
|
US10471028B2
(en)
|
2014-06-13 |
2019-11-12 |
University Of Rochester |
Small molecule efflux pump inhibitors
|
GB201411236D0
(en)
|
2014-06-25 |
2014-08-06 |
Takeda Pharmaceutical |
Novel compounds
|
GB201411239D0
(en)
|
2014-06-25 |
2014-08-06 |
Takeda Pharmaceutical |
Novel compounds
|
TW201613878A
(en)
|
2014-07-09 |
2016-04-16 |
Janssen Pharmaceutica Nv |
Pyrazine GPR40 agonists for the treatment of type II diabetes
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
EP3174537B1
(de)
|
2014-07-29 |
2021-06-23 |
Merck Sharp & Dohme Corp. |
Monocyclische isoxazoline als hemmer des cholesterinestertransferproteins
|
WO2016022742A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
WO2016019587A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[7, 6]-fused bicyclic antidiabetic compounds
|
US10662171B2
(en)
|
2014-08-08 |
2020-05-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
CA2952541C
(en)
|
2014-08-14 |
2019-10-01 |
F. Hoffmann-La Roche Ag |
Pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
GB201414730D0
(en)
|
2014-08-19 |
2014-10-01 |
Tpp Global Dev Ltd |
Pharmaceutical compound
|
WO2016032120A1
(ko)
|
2014-08-27 |
2016-03-03 |
씨제이헬스케어 주식회사 |
신규한 아미노-페닐-설포닐-아세테이트 유도체 및 이의 용도
|
MA40470A
(fr)
|
2014-08-27 |
2016-03-03 |
Gilead Sciences Inc |
Composés et procédés d'inhibition des histones déméthylases
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
CN106999536B
(zh)
|
2014-09-11 |
2020-11-27 |
百时美施贵宝公司 |
Pd-1/pd-l1及cd80(b7-1)/pd-l1蛋白质/蛋白质相互作用的大环抑制剂
|
UY35733A
(es)
|
2014-09-12 |
2016-04-01 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Inhibidores macrocíclicos de las interacciones proteína/proteína pd-1/pd-l1 y cd80(b7-1)/pd-l1 i.p.c.
|
TW201625527A
(zh)
|
2014-09-19 |
2016-07-16 |
財團法人臺灣基督長老教會馬偕紀念社會事業基金會馬偕紀念醫院 |
苯并雜環化合物及其應用
|
AU2015320675B2
(en)
|
2014-09-26 |
2018-10-18 |
Gilead Sciences, Inc. |
Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
|
EP3204379B1
(de)
|
2014-10-10 |
2019-03-06 |
Genentech, Inc. |
Pyrrolidinamid-verbindungen als histondemethylase-inhibitoren
|
WO2016060963A1
(en)
|
2014-10-14 |
2016-04-21 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
ES2869910T3
(es)
|
2014-10-17 |
2021-10-26 |
Hyundai Pharm Co Ltd |
Preparación compuesta, que contiene un nuevo derivado de ácido 3-(4-(benciloxi)fenil)hex-4-inoico y otro principio activo, para prevenir o tratar enfermedades metabólicas
|
PE20190710A1
(es)
|
2014-10-24 |
2019-05-17 |
Bristol Myers Squibb Co |
Compuestos de indol carboxamida utiles como inhibidores de cinasas
|
KR101857146B1
(ko)
|
2014-10-28 |
2018-05-11 |
삼성에스디아이 주식회사 |
유기 광전자 소자 및 표시 장치
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
GB201419579D0
(en)
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
CN107108556B
(zh)
|
2014-11-03 |
2020-09-29 |
艾欧米制药有限公司 |
药用化合物
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
AR102537A1
(es)
|
2014-11-05 |
2017-03-08 |
Flexus Biosciences Inc |
Agentes inmunomoduladores
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
MX2017007138A
(es)
|
2014-12-03 |
2017-08-28 |
Juno Therapeutics Inc |
Metodos y composiciones para terapia celular adoptiva.
|
JP2017537929A
(ja)
|
2014-12-05 |
2017-12-21 |
ジェネンテック, インコーポレイテッド |
Pd−1軸アンタゴニスト及びhpk1アンタゴニストを用いたがん治療のための方法及び組成物
|
JP6821568B2
(ja)
|
2014-12-15 |
2021-01-27 |
ベリカム ファーマシューティカルズ, インコーポレイテッド |
治療用細胞のコントロールされた排除方法
|
WO2016102438A1
(en)
|
2014-12-23 |
2016-06-30 |
F. Hoffmann-La Roche Ag |
Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidine analogues
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
WO2016107832A1
(en)
|
2014-12-30 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection
|
WO2016107833A1
(en)
|
2014-12-31 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr
|
US10435402B2
(en)
|
2015-01-08 |
2019-10-08 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
WO2016120186A1
(en)
|
2015-01-27 |
2016-08-04 |
F. Hoffmann-La Roche Ag |
Recombinant hbv cccdna, the method to generate thereof and the use thereof
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CA2981753A1
(en)
|
2015-02-06 |
2016-08-11 |
Unity Biotechnology, Inc. |
Compounds and uses in treatment of senescence-associated conditions
|
JP6435054B2
(ja)
|
2015-02-11 |
2018-12-05 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の治療及び予防のための新規2−オキソ−6,7−ジヒドロベンゾ[a]キノリジン−3−カルボン酸誘導体
|
WO2016128908A1
(en)
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
MX2017011614A
(es)
|
2015-03-10 |
2018-03-23 |
Aurigene Discovery Tech Ltd |
Compuestos de 1,3,4-oxadiazol y tiadiazol como inmunomoduladores.
|
CN107427497A
(zh)
|
2015-03-10 |
2017-12-01 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的3‑取代的1,3,4‑噁二唑和噻二唑化合物
|
HUE058274T2
(hu)
|
2015-03-10 |
2022-07-28 |
Aurigene Discovery Tech Ltd |
1,2,4-oxadiazol és tiadiazol-vegyületek, mint immunmodulátorok
|
JP2018507894A
(ja)
|
2015-03-10 |
2018-03-22 |
オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited |
免疫調節剤としての3−置換−1,2,4−オキサジアゾールおよびチアジアゾール化合物
|
CN107427491A
(zh)
|
2015-03-10 |
2017-12-01 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的治疗性环状化合物
|
CN104876912B
(zh)
|
2015-04-08 |
2017-07-21 |
苏州云轩医药科技有限公司 |
Wnt信号通路抑制剂及其应用
|
NZ736709A
(en)
|
2015-05-15 |
2019-05-31 |
Gilead Sciences Inc |
Benzimidazole and imidazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase
|
EP3303586A1
(de)
|
2015-05-29 |
2018-04-11 |
Juno Therapeutics, Inc. |
Zusammensetzung und verfahren zur regulierung von inhibitorischen wechselwirkungen in gentechnisch veränderten zellen
|
TWI703150B
(zh)
|
2015-06-04 |
2020-09-01 |
美商庫拉腫瘤技術股份有限公司 |
用於抑制menin及mll蛋白之交互作用的方法及組合物
|
WO2016197987A1
(zh)
|
2015-06-12 |
2016-12-15 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
EP3322420B1
(de)
|
2015-07-13 |
2021-12-29 |
Merck Sharp & Dohme Corp. |
Bicyclische heterocyclen als inhibitoren des cholesterinestertransferproteins
|
EP3331860B1
(de)
|
2015-08-07 |
2019-07-17 |
Boehringer Ingelheim International GmbH |
Indanylaminopyridylcyclopropancarbonsäuren, pharmazeutische zusammensetzungen daraus und verwendungen davon
|
US9920040B2
(en)
|
2015-08-12 |
2018-03-20 |
Janssen Pharmaceutica Nv |
GPR40 agonists for the treatment of type II diabetes
|
US9908873B2
(en)
|
2015-08-12 |
2018-03-06 |
Janssen Pharmaceutica Nv |
GPR40 agonists for the treatment of type II diabetes
|
US9856245B2
(en)
|
2015-08-12 |
2018-01-02 |
Janssen Pharmaceutica Nv |
GPR40 agonists for the treatment of type II diabetes
|
WO2017031392A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Florida Research Foundation, Incorporated |
Lipid compounds for treatment of obesity, hypertension and metabolic syndrome
|
WO2017042121A1
(en)
|
2015-09-09 |
2017-03-16 |
Boehringer Ingelheim International Gmbh |
[{[2,3-dihydro-1h-inden-1-yl]amino}-2h,3h-furo[3,2-b]pyridin-3-yl]acetic acids, pharmaceutical compositions and uses thereof
|
SG10202110257UA
(en)
|
2015-09-17 |
2021-10-28 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
WO2017079669A1
(en)
|
2015-11-04 |
2017-05-11 |
Incyte Corporation |
Pharmaceutical compositions and methods for indoleamine 2,3-dioxygenase inhibition and indications therefor
|
SG10202004618TA
(en)
|
2015-11-19 |
2020-06-29 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
BR112018011131A2
(pt)
|
2015-12-07 |
2018-11-21 |
Kyoto University |
terapia de combinação baseada em inibidores de sinal de pd-1
|
EP3390361B1
(de)
|
2015-12-17 |
2022-03-16 |
Incyte Corporation |
N-phenyl-pyridin-2-carboxamid- derivate und ihre verwendung als pd-1/pd-l1 protein/protein-interaktions- modulatoren
|
UA126113C2
(uk)
|
2015-12-22 |
2022-08-17 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як імуномодулятори
|
US10800780B2
(en)
|
2015-12-24 |
2020-10-13 |
Genentech, Inc. |
TDO2 Inhibitors
|
EP3190103A1
(de)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitoren der pd-1/pd-l1-protein-/proteinwechselwirkung
|
CA3014774A1
(en)
|
2016-02-17 |
2017-08-24 |
Children's Medical Center Corporation |
Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders
|
US10143746B2
(en)
|
2016-03-04 |
2018-12-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9798514B2
(en)
|
2016-03-09 |
2017-10-24 |
Spotify Ab |
System and method for color beat display in a media content environment
|
US20190127314A1
(en)
|
2016-03-23 |
2019-05-02 |
Symrise Ag |
Homovanillic acid ester for reducing or inhibiting fatty acid absorption in the small intestine
|
EP3436003B1
(de)
|
2016-03-29 |
2023-08-23 |
Merck Sharp & Dohme LLC |
Antidiabetische bicyclische verbindungen
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2017180457A1
(en)
|
2016-04-11 |
2017-10-19 |
Janssen Pharmaceutica Nv |
Gpr40 agonists in anti-diabetic drug combinations
|
WO2017180571A1
(en)
|
2016-04-11 |
2017-10-19 |
Janssen Pharmaceutica Nv |
Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
|
US20190062272A1
(en)
|
2016-04-13 |
2019-02-28 |
Capten Therapeutics Inc. |
Small molecules for immunogenic treatment of cancer
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
EP3450423B1
(de)
|
2016-05-23 |
2022-06-15 |
Institute of Materia Medica, Chinese Academy of Medical Sciences |
Benzylphenyletherderivat, herstellungsverfahren dafür und pharmazeutische zusammensetzung und verwendungen davon
|
WO2017201683A1
(en)
|
2016-05-25 |
2017-11-30 |
Merck Sharp & Dohme Corp. |
Substituted tetrahydroisoquinoline compounds useful as gpr120 agonists
|
SG11201810423XA
(en)
|
2016-05-26 |
2018-12-28 |
Merck Patent Gmbh |
Pd-1 / pd-l1 inhibitors for cancer treatment
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CA3028685A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
KR102401963B1
(ko)
*
|
2016-06-27 |
2022-05-25 |
케모센트릭스, 인크. |
면역조절제 화합물
|
CA3029991A1
(en)
|
2016-07-08 |
2018-01-11 |
Bristol-Myers Squibb Company |
1,3-dihydroxy-phenyl derivatives useful as immunomodulators
|
EP3493804A1
(de)
|
2016-08-03 |
2019-06-12 |
Arising International, Inc. |
Symmetrische oder semisymmetrische verbindungen als immunmodulatoren
|
EP3281937A1
(de)
|
2016-08-09 |
2018-02-14 |
Dompé farmaceutici S.p.A. |
Sulfonamide als gpr40- und gpr120-agonisten
|
US10563620B2
(en)
|
2016-08-12 |
2020-02-18 |
Rolls-Royce North American Technologies Inc. |
Expandable exhaust cone
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US10734026B2
(en)
|
2016-09-01 |
2020-08-04 |
Facebook, Inc. |
Systems and methods for dynamically providing video content based on declarative instructions
|
US20180065917A1
(en)
|
2016-09-02 |
2018-03-08 |
Polaris Pharmaceuticals, Inc. |
Immune checkpoint inhibitors, compositions and methods thereof
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
WO2018053302A1
(en)
|
2016-09-19 |
2018-03-22 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for the inhibition of indoleamine-2,3-dioxygenase activity and use thereof
|
US10988433B2
(en)
|
2016-10-25 |
2021-04-27 |
Janssen Pharmaceutica Nv |
Cyclohexyl GPR40 agonists for the treatment of type II diabetes
|
EP3532458B1
(de)
|
2016-10-25 |
2021-01-20 |
Boehringer Ingelheim International GmbH |
Benzylaminopyridylcyclopropancarbonsäuren, pharmazeutische zusammensetzungen und verwendungen davon
|
JP7008704B2
(ja)
|
2016-11-28 |
2022-01-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
インダニルアミノピリジルシクロプロパンカルボン酸、その医薬組成物及び使用
|
EP3551176A4
(de)
|
2016-12-06 |
2020-06-24 |
Merck Sharp & Dohme Corp. |
Antidiabetische heterocyclische verbindungen
|
KR102007633B1
(ko)
|
2016-12-15 |
2019-08-06 |
일동제약(주) |
신규 페닐 프로피온 산 유도체 및 이의 용도
|
EP3558298A4
(de)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
Antidiabetische spirochromanverbindungen
|
JP7106572B2
(ja)
|
2016-12-20 |
2022-07-26 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な化合物
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
ES2929193T3
(es)
|
2016-12-22 |
2022-11-25 |
Incyte Corp |
Derivados de tetrahidro imidazo[4,5-c]piridina como inductores de la internalización de PD-L1
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
EP3558963B1
(de)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Bicyclische heteroaromatische verbindungen als immunmodulatoren
|
AU2017382870B2
(en)
|
2016-12-22 |
2022-03-24 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
EP3564237A4
(de)
|
2016-12-29 |
2020-06-10 |
Shenzhen Chipscreen Biosciences Co., Ltd. |
Harnstoffverbindung sowie herstellungsverfahren und verwendung davon
|
JP7023969B2
(ja)
|
2017-01-26 |
2022-02-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンジルアミノピリジルシクロプロパンカルボン酸、その医薬組成物及び使用
|
US10603317B2
(en)
|
2017-01-26 |
2020-03-31 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
EP3573959B1
(de)
|
2017-01-26 |
2021-07-28 |
Boehringer Ingelheim International GmbH |
Benzylaminopyrazinyl-cyclopropancarbonsäuren, pharmazeutische zusammensetzungen und verwendungen davon
|
CN110214135B
(zh)
|
2017-01-26 |
2023-02-21 |
勃林格殷格翰国际有限公司 |
茚满基氨基吡嗪基环丙烷羧酸、药物组合物及其用途
|
EP3573953A1
(de)
|
2017-01-26 |
2019-12-04 |
Boehringer Ingelheim International GmbH |
Benzyloxypyridylcyclopropancarbonsäuren, pharmazeutische zusammensetzungen und verwendungen davon
|
EP3580222B1
(de)
|
2017-02-08 |
2021-04-07 |
Boehringer Ingelheim International GmbH |
Indanylaminoazadihydrobenzofuranylessigsäuren, pharmazeutische zusammensetzungen zur behandlung von diabetes
|
CN110402248B
(zh)
|
2017-03-15 |
2023-01-06 |
豪夫迈·罗氏有限公司 |
作为hpk1抑制剂的氮杂吲哚类
|
GB201704714D0
(en)
|
2017-03-24 |
2017-05-10 |
Caldan Therapeutics Ltd |
Pharmaceutical compounds
|
JP7150745B2
(ja)
|
2017-03-27 |
2022-10-11 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調節剤としての置換イソキノリン誘導体
|
MA48994A
(fr)
|
2017-03-30 |
2020-02-05 |
Hoffmann La Roche |
Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
|
JP7154221B2
(ja)
|
2017-03-30 |
2022-10-17 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Hpk1の阻害剤としてのナフチリジン
|
US11186565B2
(en)
|
2017-03-31 |
2021-11-30 |
Takeda Pharmaceutical Company Limited |
Aromatic compound
|
AR111199A1
(es)
|
2017-03-31 |
2019-06-12 |
Takeda Pharmaceuticals Co |
Compuesto aromático agonista de gpr40
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
CN108794422B
(zh)
|
2017-04-26 |
2022-07-01 |
南京圣和药业股份有限公司 |
作为pd-l1抑制剂的杂环类化合物
|
WO2019008156A1
(en)
|
2017-07-07 |
2019-01-10 |
Rijksuniversiteit Groningen |
INHIBITORS OF PROTEIN / PROTEIN INTERACTION PD-1 / PD-L1
|
JP7185681B2
(ja)
|
2017-07-28 |
2022-12-07 |
ケモセントリックス,インコーポレイティド |
免疫調節化合物
|
AU2018313744C1
(en)
|
2017-08-08 |
2023-07-27 |
Chemocentryx, Inc. |
Macrocyclic immunomodulators
|
EP3669872A4
(de)
|
2017-08-18 |
2021-05-05 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Formylpyridinderivat mit pd-l1-hemmender wirkung, herstellungsverfahren dafür und verwendung davon
|
WO2019059411A1
(en)
|
2017-09-20 |
2019-03-28 |
Chugai Seiyaku Kabushiki Kaisha |
DOSAGE FOR POLYTHERAPY USING PD-1 AXIS BINDING ANTAGONISTS AND GPC3 TARGETING AGENT
|
CN111051332A
(zh)
|
2017-10-03 |
2020-04-21 |
百时美施贵宝公司 |
免疫调节剂
|
WO2019074241A1
(ko)
|
2017-10-11 |
2019-04-18 |
정원혁 |
페닐아세틸렌 유도체를 포함하는 pd-1과 pd-l1의 상호작용 억제제
|
CN109678796B
(zh)
|
2017-10-19 |
2023-01-10 |
上海长森药业有限公司 |
Pd-1/pd-l1小分子抑制剂及其制备方法和用途
|
SG11202005962YA
(en)
|
2017-12-29 |
2020-07-29 |
Guangzhou Maxinovel Pharmaceuticals Co Ltd |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
WO2019160882A1
(en)
|
2018-02-13 |
2019-08-22 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
WO2019165043A2
(en)
|
2018-02-22 |
2019-08-29 |
Chemocentryx, Inc. |
Indane-amines as pd-l1 antagonists
|
CN111788193B
(zh)
|
2018-03-13 |
2023-04-04 |
广东东阳光药业有限公司 |
Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
|
CN112105610B
(zh)
|
2018-03-13 |
2024-01-26 |
朱比连特普罗德尔有限责任公司 |
作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物
|
MD3774791T2
(ro)
|
2018-03-30 |
2023-06-30 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
US10899735B2
(en)
|
2018-04-19 |
2021-01-26 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
LT3790877T
(lt)
|
2018-05-11 |
2023-05-10 |
Incyte Corporation |
Tetrahidro-imidazo[4,5-c]piridino dariniai kaip pd-l1 imunomoduliatoriai
|
JP7105359B2
(ja)
|
2018-07-13 |
2022-07-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Pd-1/pd-l1阻害剤
|
WO2020011246A1
(zh)
|
2018-07-13 |
2020-01-16 |
广州丹康医药生物有限公司 |
含苯环的化合物、其制备方法及应用
|